Hence, the predicted interaction between adiponectin and PPAR-γ may be related to the AMK signaling pathway (−log(FDR) = 5.37), adipocytokine signaling pathway (−log(FDR) = 4.58), and nonalcoholic fatty liver disease (−log(FDR) = 3.43). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.